Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
D000731:Androstanes / Q000378:metabolism; D000735:Androstenedione / Q000378:metabolism; D004054:Diethylstilbestrol / Q000494:pharmacology*; D013196:Dihydrotestosterone / Q000378:metabolism; D005866:Gestonorone Caproate / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D010088:Oxidoreductases; D011467:Prostate / Q000201:enzymology / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D013739:Testosterone / Q000378:metabolism*; D014316:Tritium
D000731:Androstanes; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone; D000735:Androstenedione; D004054:Diethylstilbestrol; D010088:Oxidoreductases; D005866:Gestonorone Caproate